National Institute on Drug Abuse; Notice of Closed Meetings, 48942 [2019-20050]
Download as PDF
<![CDATA[
48942
Federal Register / Vol. 84, No. 180 / Tuesday, September 17, 2019 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meetings
jbell on DSK3GLQ082PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; Limited
Competition Cohort Studies of HIV/AIDS and
Substance Abuse (U01 Clinical Trial Not
Allowed)
Date: October 1, 2019.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate
cooperative agreement applications.
Place: National Institutes of Health,
Neuroscience Center Building (NSC), 6001
Executive Boulevard, Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Hiromi Ono, Ph.D.,
Scientific Review Officer, Office of
Extramural Affairs, National Institute on
Drug Abuse, National Institutes of Health,
DHHS, 6001 Executive Boulevard, Room
4238, MSC 9550 Bethesda, MD 20892, 301–
402–6020, hiromi.ono@nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; (T32)
Ruth L. Kirschstein National Research
Service Award (NRSA) Institutional Research
Training Grants.
Date: November 6–7, 2019.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center Building (NSC), 6001
Executive Boulevard, Rockville, MD 20852.
Contact Person: Susan O McGuire, Ph.D.,
Scientific Review Officer, Office of
Extramural Affairs, National Institute on
Drug Abuse, National Institutes of Health,
DHHS, 6001 Executive Blvd., Room 4245,
Rockville, MD 20852, 301–435–1426,
mcguireso@mail.nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; Limited
Competition for Adolescent Brain Cognitive
Development (ABCD) Study—Linked
Research Project Sites (Collaborative U01
Clinical Trial Not Allowed).
Date: November 8, 2019.
Time: 8:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate
cooperative agreement applications.
VerDate Sep<11>2014
17:05 Sep 16, 2019
Jkt 247001
Place: Cambria Hotel Rockville, 1 Helen
Heneghan Way, Rockville, MD 20850.
Contact Person: Yvonne Owens Ferguson,
Ph.D., Scientific Review Officer, Office of
Extramural Policy and Review, Division of
Extramural Research, National Institute on
Drug Abuse, NIH/DHHS, 6001 Executive
Blvd., Rm. 4234, Bethesda, MD 20892, 301–
402–7371, yvonne.ferguson@nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; Limited
Competition for Adolescent Brain Cognitive
Development (ABCD) Study—Data Analysis,
Informatics and Resource Center &
Coordinating Center (U24 Clinical Trial Not
Allowed).
Date: November 8, 2019.
Time: 8:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate
cooperative agreement applications.
Place: Cambria Hotel Rockville, 1 Helen
Heneghan Way, Rockville, MD 20850.
Contact Person: Yvonne Owens Ferguson,
Ph.D., Scientific Review Officer, Office of
Extramural Policy and Review, Division of
Extramural Research, National Institute on
Drug Abuse, NIH/DHHS, 6001 Executive
Blvd., Rm. 4234, Bethesda, MD 20892, 301–
402–7371, yvonne.ferguson@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
Dated: September 11, 2019.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–20050 Filed 9–16–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Amended Notice of
Meeting
Notice is hereby given of a change for
the meeting of the Developmental
Biology Subcommittee, October 03,
2019, 8:00 a.m. to 5:00 p.m., Embassy
Suites—Chevy Chase Pavilion, which
was published in the Federal Register
on August 19, 2019, 84 FR 42936.
The name of the meeting has been
corrected. The meeting is closed to the
public.
Dated: September 11, 2019.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–20029 Filed 9–16–19; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Neuroimmune Interactions and
Neuroinflammation.
Date: October 16, 2019.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference
Call).
Contact Person: Linda MacArthur, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4187,
Bethesda, MD 20892, (301) 537–9986,
macarthurlh@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Hypersensitivity, Allergies and Mucosal
Immunology.
Date: October 17–18, 2019.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bahia Resort Hotel, 998 West
Mission Bay Drive, San Diego, CA 92109.
Contact Person: Alok Mulky, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4203,
Bethesda, MD 20892, (301) 435–3566,
alok.mulky@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Interdisciplinary Molecular
Sciences and Training.
Date: October 17, 2019.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference
Call).
Contact Person: Lystranne Alysia Maynard
Smith, Ph.D., Scientific Review Officer,
E:\FR\FM\17SEN1.SGM
17SEN1
]]>Agencies
[Federal Register Volume 84, Number 180 (Tuesday, September 17, 2019)]
[Notices]
[Page 48942]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-20050]
[[Page 48942]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Limited Competition Cohort Studies of HIV/AIDS and
Substance Abuse (U01 Clinical Trial Not Allowed)
Date: October 1, 2019.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate cooperative agreement
applications.
Place: National Institutes of Health, Neuroscience Center
Building (NSC), 6001 Executive Boulevard, Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Hiromi Ono, Ph.D., Scientific Review Officer,
Office of Extramural Affairs, National Institute on Drug Abuse,
National Institutes of Health, DHHS, 6001 Executive Boulevard, Room
4238, MSC 9550 Bethesda, MD 20892, 301-402-6020, [email protected].
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; (T32) Ruth L. Kirschstein National Research Service
Award (NRSA) Institutional Research Training Grants.
Date: November 6-7, 2019.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center
Building (NSC), 6001 Executive Boulevard, Rockville, MD 20852.
Contact Person: Susan O McGuire, Ph.D., Scientific Review
Officer, Office of Extramural Affairs, National Institute on Drug
Abuse, National Institutes of Health, DHHS, 6001 Executive Blvd.,
Room 4245, Rockville, MD 20852, 301-435-1426,
[email protected].
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Limited Competition for Adolescent Brain Cognitive
Development (ABCD) Study--Linked Research Project Sites
(Collaborative U01 Clinical Trial Not Allowed).
Date: November 8, 2019.
Time: 8:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate cooperative agreement
applications.
Place: Cambria Hotel Rockville, 1 Helen Heneghan Way, Rockville,
MD 20850.
Contact Person: Yvonne Owens Ferguson, Ph.D., Scientific Review
Officer, Office of Extramural Policy and Review, Division of
Extramural Research, National Institute on Drug Abuse, NIH/DHHS,
6001 Executive Blvd., Rm. 4234, Bethesda, MD 20892, 301-402-7371,
[email protected].
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Limited Competition for Adolescent Brain Cognitive
Development (ABCD) Study--Data Analysis, Informatics and Resource
Center & Coordinating Center (U24 Clinical Trial Not Allowed).
Date: November 8, 2019.
Time: 8:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate cooperative agreement
applications.
Place: Cambria Hotel Rockville, 1 Helen Heneghan Way, Rockville,
MD 20850.
Contact Person: Yvonne Owens Ferguson, Ph.D., Scientific Review
Officer, Office of Extramural Policy and Review, Division of
Extramural Research, National Institute on Drug Abuse, NIH/DHHS,
6001 Executive Blvd., Rm. 4234, Bethesda, MD 20892, 301-402-7371,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.279, Drug
Abuse and Addiction Research Programs, National Institutes of
Health, HHS)
Dated: September 11, 2019.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-20050 Filed 9-16-19; 8:45 am]
BILLING CODE 4140-01-P
